affects vascular tone by multiple mechanisms, including inhibition of the Rho/Rho kinase-mediated Ca 2ϩ sensitization, a process identified as Ca 2ϩ desensitization. Ca 2ϩ desensitization is mediated probably by both cGMP-and cAMP-dependent protein kinases (cGKI and PKA). We investigate to which extent Ca 2ϩ desensitization is initiated by cGKI and PKA. cGMP/cAMP-induced relaxation was studied at constant [Ca 2ϩ ] in permeabilized aortas from wild-type and cGKIdeficient mice. [Ca 2ϩ ] increased aortic tone in the absence and presence of 50 M GTP␥S with EC 50 values of 160 and 30 nM, respectively. In the absence of GTP␥S, the EC 50 for [Ca 2ϩ ] was shifted rightward from 0.16 M to 0.43 and 0.82 M by 1 and 300 M 8-bromo-cGMP (8-Br-cGMP), and to 8 M by 10 M Y-27632. Contractions induced by 300 nM [Ca 2ϩ ] were relaxed by 8-Br-cGMP with an EC 50 of 2.6 M. Surprisingly, [Ca 2ϩ ]-induced contractions were also relaxed by 8-Br-cGMP in aortas from cGKI Ϫ/Ϫ mice (EC50 of 19 M). Western blot analysis of the vasodilator-stimulated phosphoprotein indicated "cross"-activation of PKA by 1 mM 8-Br-cGMP in aortic smooth muscle cells from cGKI Ϫ/Ϫ mice. Indeed, the PKA inhibitor peptide (PKI 5-24) completely abolished the relaxant effect of 8-Br-cGMP in muscles from cGKI Ϫ/Ϫ mice and to 65% in wild-type aortas. The thromboxane analogue U-46619 induced contraction at constant [Ca 2ϩ ], which was only partially relaxed by 8-Br-cGMP but completely relaxed by Y-27632. The effect of 8-BrcGMP on U-46619-induced contraction was attenuated by PKI 5-24. These results show that cGKI has only a small inhibitory effect on Ca 2ϩ sensitization in murine aortas. (14, 23, 24) . Contraction can also be initiated by certain agonists at constant [Ca 2ϩ ] i , a phenomenon called Ca 2ϩ sensitization, which increases phosphorylation by inhibition of MLCP activity mostly due to phosphorylation of the myosin phosphatase targeting subunit 1 (MYPT1) and/or the protein kinase C-potentiated inhibitor CPI-17 by Rho kinase (ROCK) and protein kinase C (PKC), respectively (9, 42).
PHOSPHORYLATION of the smooth muscle myosin regulatory light chain correlates with smooth muscle tone and is determined by the balance between myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP) activity. To initiate contraction, this balance is moved toward phosphorylation via activation of MLCK by an increased intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) that is triggered by an action potential or contractile agonists (14, 23, 24) . Contraction can also be initiated by certain agonists at constant [Ca 2ϩ ] i , a phenomenon called Ca 2ϩ sensitization, which increases phosphorylation by inhibition of MLCP activity mostly due to phosphorylation of the myosin phosphatase targeting subunit 1 (MYPT1) and/or the protein kinase C-potentiated inhibitor CPI-17 by Rho kinase (ROCK) and protein kinase C (PKC), respectively (9, 42) .
Relaxation is achieved either passively by removal of the respective stimulus or actively by agonists that move the balance toward dephosphorylation via reducing [Ca 2ϩ ] i and increasing MLCP activity. The most prominent representative of those agonists in vascular smooth muscle is nitric oxide (NO), which relaxes mainly via production of the cyclic nucleotide cGMP and subsequent activation of cGMP-dependent protein kinase I (cGKI) (29) . The involvement of cGKI in this cascade was verified by deleting the cGKI gene in mice (36) . At least four different downstream pathways exist by which cGKI can promote relaxation (21) . Intracellular [Ca 2ϩ ] is reduced by 1) inhibiting Ca 2ϩ release from intracellular stores via phosphorylation of the inositol receptor-associated G-kinase substrate (IRAG) (16) ; 2) attenuating inositol (1, 4, 5) trisphosphate [Ins(1,4,5)P 3 ]-mediated Ca 2ϩ release by calming the synthesis of Ins(1,4,5)P 3 via modulation of the regulator of G protein signaling 2 (RGS-2), which regulates GTPase activity of G q (44) ; and 3) hyperpolarization of the membrane potential and closure of L-type calcium channels via cGKIinduced increase in the open probability of Ca 2ϩ -activated K ϩ channels (BK Ca ) (1, 13, 38, 50 ). An alternative mechanism to induce relaxation at constant [Ca 2ϩ ] is to increase MLCP activity, a process that has been described as Ca 2ϩ desensitization (35, 42) . cGMP/cGKI has been reported to increase the activity of myosin phosphatase leading to dephosphorylation of regulatory light chain (RLC) (9, 28, 49) , probably via phosphorylation of MYPT1 (43, 49) , albeit at another phosphorylation site than ROCK (49) .
However, in recent times it became obvious that cGMP relaxed smooth muscle preparations in the absence of cGKI (3, 38) . It was possible that some of the cGKI targets previously identified by NO-cGMP-dependent phosphorylation (6, 38, 39, 41, 49) were phosphorylated by cGMP-activated, cAMP-dependent protein kinase (PKA). Consequently, we hypothesized that part of cGMP-mediated Ca 2ϩ desensitization may be performed by activation of PKA rather than of cGKI. For this purpose, the contribution of cGKI and PKA to the regulation of vascular tone by cGMP was investigated at constant [Ca 2ϩ ] in permeabilized murine aortic strips from wild-type and cGKIdeficient mice. The results show that cGKI only slightly affects Ca 2ϩ desensitization in permeabilized aortic smooth muscle.
MATERIALS AND METHODS
All experiments complied with the animal protection laws of Germany. Wild-type mice and mice lacking cGMP-dependent protein kinase I (cGKI Ϫ/Ϫ mice) were bred as described (47) . Mice were killed according German legalization, under a license granted from the German government (Regierung von Oberbayern, 2531-5/05) to conduct animal research as described in our study. The thoracic aorta was isolated and cleaned from connective tissue. Aortic rings of 5 mm in width were mounted to organ baths (Myograph 601, www.dmt.dk) according to Wegener et al. (48) . Resting tension was set to 4 -5 mN. Tension was recorded isometrically at room temperature to minimize rundown of Ca 2ϩ -induced contraction (19) . Endothelium was removed by mechanical treatment. The absence of endothelium was verified by the missing relaxant effect of carbachol (10 M) .
Permeabilization was performed as described (26) . Briefly, rings were incubated in Ca 2ϩ -free solution (in mM: 97 NaCl, 5.4 KCl, 6.47 MgCl2, 5 EGTA, 0.1 DTT, 5.5 Na2ATP, 9.5 Na2-creatine phosphate, 5 glutathione, 5.6 glucose, and 10 HEPES; pH 7.4) with 520 U/ml of ␣-toxin from Staphylococcus aureus, which produced nearly maximal contraction in rings incubated at 1 M [Ca 2ϩ ]. The concentrations of free Ca 2ϩ were reached by the addition of a specified amount of CaCl2 to the Ca 2ϩ -free solution, the amount being calculated according to Brooks and Storey (4) . In the experiments with the PKA inhibitor peptide (PKI 5-24), ␤-escin was used for permeabilization to allow free diffusion for molecules up to 17,000 Da as previously described (27, 45) ; 0.04‰ bovine serum albumin was added to saturate unspecific protein binding sites. Contraction to 300 nM Ca 2ϩ was 0.37 Ϯ 0.04 (n ϭ 36) and 0.23 Ϯ 0.01 (n ϭ 98) N/m in muscles permeabilized with ␣-toxin and ␤-escin, respectively. The effect of 300 M 8-bromo-cGMP (8-Br-cGMP; www.biolog.de) was not significantly different in ␤-escin-versus ␣-toxin-permeabilized muscles (22 Ϯ 2.6%; n ϭ 6 vs. 21 Ϯ 4.4% of control; n ϭ 8).
Smooth muscle cells were isolated from the aortas of wild-type and cGKI Ϫ/Ϫ mice by enzymatic digestion and grown in DMEM (Life Technologies) as previously described (10) . Cells were kept in serumfree medium 2 days before the start of the experiments and used without any passage. Drugs or vehicle were applied for 30 min in serum-free medium.
Western blot analysis was performed by using polyclonal rabbit antisera detecting cGKI (15) , Akt (cell signaling), and vasodilatorstimulated phosphoprotein (phospho-Ser 157 -VASP; Alexis). All salts and substances were used as pure as commercially available and purchased from Sigma (www.sigma-aldrich.com) unless otherwise indicated. Drugs were applied as single quantity or cumulatively to achieve the concentrations as indicated.
Results are presented as original recordings, blots, or expressed as means Ϯ SE. Tension generated by the muscle is expressed in Newtons per meter with meter corresponding to the length of the aortic ring or in percentage of Ca 2ϩ -induced contraction. Effects of drugs were analyzed in steady-state conditions. Changes in tension were determined with respect to the resting tension in Ca 2ϩ -free conditions. Statistical comparisons of data sets were performed by a Student's t-test, comparison of curves by a two-way ANOVA using repeated measurement design using Prism 4 software (www. graphpad.com). Differences were considered significant at P Ͻ 0.05.
RESULTS

Ca
2ϩ -induced contraction and cGMP-dependent relaxation in permeabilized aorta. Raising the extracellular [Ca 2ϩ ] to 1 M had no effect on the tone of an intact aortic strip, whereas it induced a strong contraction in a permeabilized preparation. After permeabilization, aortic tone increased concentration dependently in response to a rise in [Ca 2ϩ ] with an EC 50 ] needed to half maximally contract the aortic rings were shifted to higher concentrations when 8-Br-cGMP was added, demonstrating that cGMP induced Ca 2ϩ desensitization of the aortic tone (Fig. 2C ). The EC 50 value was shifted from 160 to 430 nM and 820 nM in the presence of 1 and 300 M 8-Br-cGMP, respectively. The Ca 2ϩ -desensitizing effect of 8-Br-cGMP was weaker than that of the Rho kinase inhibitor Y-27632 (10 M), which shifted the EC 50 to 8 M (Fig. 2C) .
Dependence of cGMP-induced relaxation on PKA. 8-BrcGMP (300 M) relaxed contractions induced by 300 nM [Ca 2ϩ ] in permeabilized aorta not only from wild-type mice but also from cGKI Ϫ/Ϫ mice that lack a functional cGKI (Fig.  3, A and B) . Preincubation with PKI 5-24 (200 nM) attenuated the relaxant effect of 8-Br-cGMP in both preparations (Fig. 3,  C and D) . Maximal inhibition by PKI 5-24 was observed at 3 M. At this concentration, 300 M 8-Br-cGMP did not relax the tonus of aortic rings from cGKI Ϫ/Ϫ mice [96 Ϯ 2% (n ϭ 11) of control, P Ͼ 0.05] and only by 28 Ϯ 3% (n ϭ 10) of those from wild-type mice (Fig. 3E) . These results supported the hypothesis that the relaxant effects of 8-Br-cGMP at constant [Ca 2ϩ ] are mediated mostly by activation of PKA and only to a minor extent by cGKI. This interpretation was further strengthened by the cumulative concentration-response curves for 8-Br-cGMP shown in Fig. 3F . The fit of the data revealed that 8-Br-cGMP relaxed precontracted, permeabilized wildtype and cGKI Ϫ/Ϫ aortas with EC 50 values of 2.6 and 19 M to values of 34 and 52% of control, respectively. In the presence of 3 M PKI 5-24, the fit showed that 8-Br-cGMP relaxed precontracted aorta with an EC 50 of 0.7 M to 57% of control (Fig. 3F ). This result demonstrates that cGKI affected relaxation at constant [Ca 2ϩ ] in murine wild-type mice aorta, although only to a small extent. In the next series of experiments, the effect of PKI 5-24 on Ca 2ϩ desensitization induced by the phosphodiesterase-resistant cAMP analogue dibutyrylcAMP (db-cAMP) and 8-Br-cGMP was studied. The concentration-response curve for Ca 2ϩ in ␤-escin-permeabilized aorta was shifted to the right by db-cAMP (300 M) as well as by 8-Br-cGMP (300 M) but not in the presence of PKI 5-24 (3 M) (Fig. 4) . A similar shift was observed in the ␤-escinpermeabilized aorta of cGKI Ϫ/Ϫ mice in the presence of 8-Br-cGMP that was abolished in the presence of PKI 5-24 (3 M) (Fig. 4B) . These results show that PKI 5-24 inhibits both cAMP-and cGMP-mediated Ca 2ϩ desensitization and further support the hypothesis that cGMP-induced Ca 2ϩ desensitization in permeabilized aortic smooth muscle is mainly mediated by PKA activation.
cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein. Activity of cGKI and PKA can be monitored by phosphorylation of vasodilator-stimulated phosphoprotein (VASP), a substrate of both kinases (5). Stimulation with 8-Br-cAMP (1 mM) induced phosphorylation of VASP in aortic smooth muscle cells from wild-type and cGKI Ϫ/Ϫ mice (Fig. 5) . No effect was observed at a lower concentration (100 M). Stimulation with 8-Br-cGMP (1 mM) induced phosphorylation of VASP in cells from wild-type mice but also in those from cGKI Ϫ/Ϫ mice (Fig. 5) . A lower concentration of 8-BrcGMP (100 M) showed no effect in cells from cGKI Ϫ/Ϫ mice but showed a clear signal in cells from wild-type mice. These results demonstrate that 8-Br-cGMP induces phosphorylation of VASP in the absence of cGKI in vascular tissue, most probably via "cross"-activation of PKA. Stimulation of ␤-escin-permeabilized tissue with 1 mM 8-Br-cGMP likewise induced phosphorylation of VASP, which was attenuated in the presence of 3 M PKI 5-24 (not shown).
cGMP-induced relaxation after G-protein activation at constant [Ca 2ϩ ]. As noted previously (3, 26, 42) and shown in Fig.  1C , activation of G proteins increased contractions at constant [Ca 2ϩ ]. Stimulation of the permeabilized aorta with the stable thromboxane analogue U-46619 (30 M) and GTP␥S (50 M) at 300 nM [Ca 2ϩ ] increased the aortic tone by 49 Ϯ 6% (n ϭ 15) and 111 Ϯ 18% (n ϭ 6), respectively (Fig. 6, A, B, and D) . The ␣ 1 -adrenergic agonist phenylephrine (3 M) was almost without effect [12 Ϯ 2% (n ϭ 18); Fig. 6, C and D] . In the absence of an agonist that activated G proteins, 8-Br-cGMP (300 M) relaxed the tone at 300 nM Ca 2ϩ by 79 Ϯ 4% (n ϭ 8) and 28 Ϯ 3% (n ϭ 10) in the absence and presence of 3 M PKA inhibitor peptide, respectively (Fig. 6E) . U-46619 induced contraction to a similar level in permeabilized wild-type and cGKI Ϫ/Ϫ aortas (P Ͼ 0.05), which was relaxed to a similar level by 8-Br-cGMP in both preparations [from 149 Ϯ 6% (n ϭ 15) and 132 Ϯ 6% (n ϭ 3) to 98 Ϯ 7% (n ϭ 8) and 97 Ϯ 6% (n ϭ 3), respectively; Fig. 6E ]. 8-Br-cGMP-induced relaxation was attenuated by the PKA inhibitor peptide (P Ͻ 0.05; Fig. 5E ). In contrast, 8-Br-cGMP was unable to affect the tension elicited by 50 M GTP␥S (Fig. 6F) , whereas the Rho kinase inhibitor Y-27632 relaxed contractions induced by GTP␥S at 300 nM [Ca 2ϩ ] to 38 Ϯ 3% (n ϭ 6) of control, demonstrating that the Ca 2ϩ -desensitization process was still intact in these experimental conditions (Fig. 6G) . These results show that activation of the thromboxane receptor is much more efficient to build up contraction via Ca 2ϩ sensitization than that of the ␣ 1 -adrenergic receptor. In agreement with the above results, cGMP-dependent Ca 2ϩ desensitization via cGKI had only a marginal effect on the tone elicited by G proteindependent Ca 2ϩ sensitization.
DISCUSSION
The present study shows that 8-Br-cGMP-induced Ca 2ϩ desensitization is mediated by PKA rather than by cGKI in permeabilized murine aorta. This view is strongly supported by the findings that 8-Br-cGMP relaxed permeabilized muscles from cGKI Ϫ/Ϫ -deficient mice in the absence, but not in the presence, of the PKA inhibitor peptide. Several former studies (11, 31) have described a cross activation between cyclic nucleotides and their respective cyclic nucleotide-dependent protein kinases with respect to relaxation in smooth muscle. For example, cAMP-elevating agents relaxed pig and sheep arteries via cGKI activation (8, 22) . In skinned rat mesenteric artery, cAMP and cGMP induced Ca 2ϩ desensitization that was abolished by Rp-8-Br-cGMPS but was not inhibited by Rp-cAMPS (25) . Evidence for a cross-talk between cGMP and PKA has been reported using smooth muscle from cGKI of PKA with an inhibitory cAMP analogue (38) . cGKI-independent relaxation was also observed in permeabilized ileal muscle strips from cGKI Ϫ/Ϫ mice, although the main mechanism for cGMP-induced relaxation has been assigned to the Ca 2ϩ desensitization of the contractile system via cGKI (3) . In the present study on permeabilized murine aorta, cGMP-dependent relaxation via Ca 2ϩ desensitization was mostly mediated by PKA. In the presence of the specific PKA inhibitor peptide at 3 M, cGMP-induced relaxation was blocked by 65% in muscles from wild-type mice and was absent in the aorta from cGKI Ϫ/Ϫ mice (see Fig. 3E ). In addition, "cross"-activation of PKA with 8-Br-cGMP was indicated by 8-BrcGMP-induced phosphorylation of VASP in aortic smooth muscle cells from cGKI Ϫ/Ϫ mice. Together, these findings indicate that the relaxant effect of cGMP, at least at high concentrations, on Ca 2ϩ -induced tone of permeabilized murine aorta is mediated approximately to two-thirds by PKA and only to one-third by cGKI.
According to Francis et al. (12) , the association constant (K a ) values for activation of cGK and PKA by 8-Br-cGMP in pig coronary artery are 25 nM and 2.8 M, respectively. Slightly higher values have been reported using purified cGK and PKA (33), and 10.5 M in the rat aorta (34) . These in vivo values raise the possibility that NO can increase cGMP in vascular smooth muscle to levels that desensitize contraction by activating not only cGKI but also PKA. It should be noted that cGMP-dependent relaxation involves not only modulation of the contractile machinery but also modulation of [Ca 2ϩ ] i . Lincoln and co-workers (7, 30) already reported in 1989 and 1990 that restoration of cGKI, but not of PKA, to cGKIdepleted aortic smooth muscle cells restored the calciumlowering effects elicited by cGMP or cAMP. These findings were extended and refined by the use of cGKI knockout mice (36, 38) . Recent evidence suggests that cGKI␤ phosphorylates IRAG (40) , a protein associated with the Ins(1,4,5)P 3 receptor, that modulates Ins(1,4,5)P 3 -induced Ca 2ϩ release (16) . Because of these different modulatory pathways, it is difficult to predict which pathway is involved in various smooth muscle cells in NO-cGMP-dependent relaxation.
Another important finding of the study is that 8-Br-cGMPinduced desensitization of the contractile machinery via cGKI is rather ineffective after G-protein activation in the murine aorta. As reviewed recently (42), G-protein activation by Gprotein-coupled receptors (GPCR) induce contraction, at least partially, by activation and membrane translocation of the small GTPase RhoA. Activated RhoA, in turn, stimulates Rho kinase to subsequently phosphorylate MYPT1, leading to inhibition of MLCP activity and, thus, Ca 2ϩ sensitization. GPCR activating G-proteins of the G␣ 12/13 type, like the prostanoid receptor, have been shown to be preferentially involved in this process, whereas GPCR stimulating G q/11 -type G-proteins, like the ␣-adrenergic receptor, are supposed to activate both phospholipase C and RhoA (18, 46) . In line with this view, the prostanoid receptor agonist U-46619 and GTP␥S induced additional contraction at constant [Ca 2ϩ ] in permeabilized aortic rings, demonstrating Ca 2ϩ sensitization in this particular vascular smooth muscle. In contrast, the ␣-adrenergic receptor agonist phenylephrine barely affected contraction at constant [Ca 2ϩ ], indicating that activation of this GPCR did not induce additional contraction via Ca 2ϩ sensitization in the murine aorta, in contrast to rabbit vascular smooth muscle (20, 37 inhibition of phosphatase activity. As a consequence, contraction via Ca 2ϩ sensitization was attenuated after cGKI activation with cGMP (49) . The results obtained in permeabilized murine aorta indicate that this situation exists also vice versa. If contraction was performed via Ca 2ϩ sensitization, which may lead to phosphorylation of threonine-696, the Ca 2ϩ -desensitizing effect of cGKI/PKA activation was greatly attenuated. Thus the results suggest that phosphorylation of MYPT1 at threonine-696 by Rho kinase may likewise prevent the phosphorylation at serine-695 by cGKI/PKA and, consequently, abolish cGKI/PKA mediated relaxation.
In conclusion, 8-Br-cGMP induced Ca 2ϩ desensitization mainly via activation of PKA in murine aorta, particularly at higher concentrations, whereas cGKI played a minor part in this regulatory mechanism. After global G-protein activation, 8-Br-cGMP-induced desensitization of the contractile machinery is rather ineffective. Instead, cGMP/cGKI-mediated relaxation may use other mechanisms in murine aortic smooth muscle, i.e., relaxation of hormone-induced contractions by inhibition of Ca 2ϩ release from intracellular stores via IRAG phosphorylation (16) .
